Literature DB >> 3922841

Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.

K Gomi, M Morimoto, N Nakamizo.   

Abstract

The antiviral and anticellular activities of recombinant human interferon-gamma (Re-IFN-gamma) were compared with those of natural human interferon-gamma (IFN-gamma), natural human interferon-alpha (IFN-alpha), and recombinant human interferon-beta (ReIFN-beta). ReIFN-gamma and IFN-gamma induced the antiviral state in FL cells against Sindbis virus more rapidly than IFN-alpha or ReIFN-beta. The antiviral state induced by a short exposure time to IFN-gamma declined rapidly after the removal of IFN-gamma and the incubation of FL cells in fresh medium, whereas that induced by ReIFN-gamma was persistent. However, other characteristics of the antiviral activity of ReIFN-gamma were shown to be very similar to those of IFN-gamma (e.g., stability at 56 degrees or pH 2.0, and neutralization by anti-IFN serum). The anticellular spectrum of ReIFN-gamma or IFN-gamma against 26 human cell lines differed in some respects from that of IFN-alpha or ReIFN-beta, since ReIFN-gamma and IFN-gamma were more effective at inhibiting the growth of human carcinoma or sarcoma cell lines. The IC50 (IFN concentration required for 50% growth inhibition) values of ReIFN-gamma were several times smaller than those of IFN-gamma in all cell lines sensitive to both IFNs. ReIFN-gamma and IFN-gamma, but not IFN-alpha or ReIFN-beta, were cytotoxic against HeLa S3 cells. These cytotoxicities of both IFNs were inactivated by treatment at 56 degrees or pH 2.0 and by anti-ReIFN-gamma serum. These results indicate that the characteristics of antiviral and anticellular activities of ReIFN-gamma are somewhat different from those of other IFNs including IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922841

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  6 in total

1.  Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Preparation of bioactive interferon alpha-loaded polysaccharide nanoparticles using a new approach of temperature-induced water phase/water-phase emulsion.

Authors:  Guang Liu; Dong Xu; Mier Jiang; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2012-09-07

3.  Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.

Authors:  K Gomi; H Ohno; K Nomura; M Okabe; K Kobayashi; H Niitani
Journal:  Jpn J Cancer Res       Date:  1992-05

4.  Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells.

Authors:  A Okamoto; A Asai; H Saito; M Okabe; K Gomi
Journal:  Jpn J Cancer Res       Date:  1994-12

5.  Analysis of DNA fragmentation in human uterine cervix carcinoma HeLa S3 cells treated with duocarmycins or other antitumor agents by pulse field gel electrophoresis.

Authors:  A Okamoto; M Okabe; K Gomi
Journal:  Jpn J Cancer Res       Date:  1993-01

6.  Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.

Authors:  K Gomi; E Kobayashi; K Miyoshi; T Ashizawa; A Okamoto; T Ogawa; S Katsumata; A Mihara; M Okabe; T Hirata
Journal:  Jpn J Cancer Res       Date:  1992-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.